Bioconductor vs Maven Central
Bioconductor
bioconductor.orgMaven Central
central.sonatype.comSide by side
| Figure | Bioconductor | Maven Central |
|---|---|---|
| Price from | Free | Free |
| Free plan | Yes | Yes |
| Free trial | — | — |
| Open source | Yes | — |
| Web | Yes | Yes |
| Windows | Yes | — |
| macOS | Yes | — |
| Linux | Yes | — |
| API | — | Yes |
| Self-hosted | Yes | — |
| Plans published | 2 | 2 |
| Spec score · Package Registries | 9.1 (#1) | 7.8 (#16) |
| Support | SourceForge lists online support, documentation and videos as available support resources. | Publishers can contact [email protected] for usage reviews, higher limits, exemptions or commercial-scale publishing guidance. |
Plans
In their own words
Bioconductor
Bioconductor develops and shares free, open-source software for rigorous and reproducible analysis of biological data. It serves researchers and data scientists working with biological and genomic datasets. The project uses R, with most components distributed as R packages. Those packages support analysis of DNA microarray, sequence, flow, SNP, and other genetic or genomic data. Tools can associate genomic data with biological metadata from sources such as GenBank, Entrez genes, and PubMed. Each package includes one or more task-oriented vignettes, and reproducible research is a stated project goal. Bioconductor maintains a stable release updated twice a year and a development version for new features and packages. Each release is designed for a specific R version; the current release page lists Bioconductor 3.23 with R 4.6.0. Docker containers with preinstalled R and Bioconductor versions support reproducible environments. The project documents container deployment with Amazon ECS, Google Kubernetes Engine, Microsoft Azure Container Instances, and Docker Desktop or Docker Engine. Help is available through its Support site and community chat. The project began in 2001 and is overseen by a core team.
Maven Central
Maven Central has no write-up on Specifiction yet; its figures are above.